NEWS
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Archive tags
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
Trump’s MFN drug pricing impact still unclear in Denmark and Sweden
Category: Business News
With the US administration’s Most Favoured Nation (MFN) drug pricing policy still hanging over Europe, Denmark and Sweden, two of the affected countries, are investigating its potential impact.
The MFN policy, set out in an executive order by US President Donald Trump in May 2025, aims to force global drug manufacturers to reduce the price of prescription medicines in the United States or face “additional aggressive action”. It also seeks to end the perceived ‘freeloading’ by foreign nations on American-financed innovation, calling for Europe to pay more for new medicines.
“All Nordic countries are paying attention to developments surrounding the MFN policy,” Gustaf Befrits, Health Economist at the Stockholm County Council, told Euractiv.
Source: Euractiv